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study was not reported. There was no evidence to suggest that the initial study sample was appropriate to the study question.
Study design
This was a case-control study that used a before-and-after design. The assessment of the outcomes was performed under the direction of the medical director. Three full-time nurse infection control professionals collected the infection data. The methods used to collect and evaluate the data did not change over the study periods. The study was carried out in a single centre. No follow-up period was considered in the study.
Analysis of effectiveness
The primary health outcomes used in the effectiveness analysis were the infection rate at the hospital, the number of nosocomial infections per 1000 patient-days, and the reduction in the absolute number of infections. It was not reported whether statistical analyses were conducted to ensure the comparability of groups and reduce the role of confounding factors.
Effectiveness results
The mean nosocomial infection rate was 3.34% (standard error, SE, 0.11%) in the pre-intervention period and 2.57% (SE 0.08%) in the post-intervention period.
The mean nosocomial infection rate per 1000 patient-days was 6.49 (SE 0.22) 
Clinical conclusions
The infection control programme was effective in reducing the infection rates in the hospital. Overall, the nosocomial infections decreased by more than 10%, and the proportion of patients with nosocomial infection decreased by 23% during the post-intervention period.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic analysis. A cost-consequence analysis was therefore conducted.
Direct costs
Discounting was irrelevant due to the short timeframe of the analysis. The health services costs included in the cost analysis were for equipment acquisition, space remodelling, annual reagents and supplies, and salaries plus benefits for the two technologists. The unit costs and quantities were not reported. The US weighted mean of 4 days, used as the excess duration of stay due to nosocomial infection, was considered as a proxy for cost-savings per patient related to the programme. The cost/resource boundary adopted was that of the hospital. The costs and the quantities were estimated using actual data derived from the hospital database. The resource use data were gathered from September 1992 to August 1996. The price year was not reported.
Statistical analysis of costs
The costs were treated in a deterministic way. Statistical analyses were conducted to match the data derived from the two study periods.
